
Coronavirus | Pfizer, Oxford shots effective for elderly
The Hindu
The Pfizer and Oxford-AstraZeneca vaccines for COVID-19 are highly effective in reducing severe coronavirus infection among people aged 70 years and above, according to a study.
The research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on laboratory confirmed symptomatic disease in individuals aged 70 years or older in England.
More Related News

When the conflict in West Asia, which began with the U.S. and Israel’s attack on Iran on February 28, escalated into a regional war, analysts said that the war would last as long as Iran had missiles or until the Gulf nations ran out of interceptors. However, with “emergency” military sales, piling monetary costs and a strained supply chain, is the U.S. becoming too constrained in its effort to keep the war going — both militarily and monetarily?












